Spots Global Cancer Trial Database for Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies
Official Title: Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies: High-dose Cyclophosphamide Versus Plerixafor
Study ID: NCT02997813
Interventions
Study Description
Brief Summary: This is a retrospective observational cohort database analysis. The study will review retrospectively the records of patients undergoing a first peripheral blood stem cell mobilization for multiple myeloma in the databases from approximately 15 hospitals which are part of the IFM collaborative group. Patient records will be divided into two groups of 50 patients minimum, maximum 100 patients or up to the number of patient records that could be extracted. The first group of patients will have received plerixafor plus G-CSF without the administration of chemotherapy as a mobilization strategy and a second group of patients will have received cyclophosphamide plus G-CSF as a mobilization strategy. All consecutive patients with complete set of data (and who underwent apheresis) treated between 2009 and 2013 with G-CSF and plerixafor and all consecutive patients with complete data (and who underwent apheresis) treated between 2009 and 2013 with G-CSF and cyclophosphamide will be included. All data that will be analyzed will be extracted from the selected IFM institutions which are located in France.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHRU Dijon, Dijon, , France
Centre Hospitalier Universitaire (CHU) de Limoges, Limoges, , France
Centre Hospitalier Lyon Sud, Lyon, , France
CHRU Hôtel Dieu, Nantes, , France
Institut Curie Centre de Lutte Contre le Cancer (CLCC), Paris, , France
La Pitié Salpetriêre, Paris, , France
Hôpital Saint-Antoine, Paris, , France
Hôpital Robert Debré Hématologie, Reims, , France
Centre Henri Becquerel, Rouen, , France
Contact Details
Name: Xavier Leleu, Dr
Affiliation: Service des maladies du sang, Hôpital Huriez, CHRU, Lille
Role: STUDY_CHAIR
Name: Denis Caillot, Dr
Affiliation: Service d'Hématologie Clinique, Hôpital Le Bocage, CHU Dijon
Role: STUDY_DIRECTOR
Name: Eric Deconinck, Pr
Affiliation: Hématologie, Hôpital Jean Minjoz, CHU Besançon
Role: STUDY_DIRECTOR
Name: Samuel Limat, Pr
Affiliation: Pharmacie centrale, Hôpital Jean Minjoz, CHU Besançon
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
